Buy
1
Hold
0
Sell
1
Watch
1
Positive Phase 3 data (33 vs 7 hairs/cm2), huge cash-pay market (80M Americans), no approved drug for women, upcoming confirmatory trial before end of 2025, recent pullback only due to IPO lockup expiry. The presenter explicitly wants to own it before trial results.
Berkshire initiated a small position in Macy's. The stock is seen as undervalued due to its extensive real estate portfolio and restructuring efforts. The turnaround and shareholder-friendly actions could lead to meaningful upside, but retail remains challenging.
Bearish based on $2 million Big Money put trade. Trader bought September 18 $17 strike puts. Stock has been flat for 20-30 years. War not ending soon, oil prices climbing, potential target at $16.50-17 support or gap fill down to $14.


